Celsion CorpAdd to My Watchlist

CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 2.23
  • 0.05  -2.19%
    Today's Change
  • 2.28
    Previous Close
  • Today
    52 Week Low - High
4:30 pm ET 8/3/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding23 million
Market Cap$51 million
Return on Equity ttm-80.51%
Last DividendCLSN:US does not pay a dividend
EPS: Year Actual ttm-1.360
EPS: Year Est. 12/15 ttm-1.200
EPS: Quarterly Actual 3/15 -0.34
EPS: Quarterly Est. 6/15 -0.31
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-45.26
Company Description
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Net Income$-25 million
Total Assets$67 million
Web Sitewww.celsion.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!